BCL2 and fetal growth restriction: Moreover, visfatin enhanced DNA fragmentation, CASP3/7 activity, P53, CASP9, CASP8, and CASP3 expression, and the BAX/BCL2 ratio in BeWo cells, and increased CASP3 expression in normal, IUGR, PE, and GDM villous explants.